medigraphic.com
ISSN 0035-0052 (Impreso)

2020, Número 2

<< Anterior Siguiente >>

Rev Mex Pediatr 2020; 87 (2)


Neumonía adquirida en la comunidad y encefalitis por metapneumovirus humano

Hernández-Sarmiento R, Álvarez-Olmos MI, Aguirre-Zambrano C, De Zubiria D, Lozano-Jaramillo MI

Idioma: Español
Referencias bibliográficas: 29
Paginas: 65-69
Archivo PDF: 262.57 Kb.


RESUMEN

El metapneumovirus humano es un virus ARN, clasificado en el grupo de patógenos respiratorios como el segundo más frecuente de la lista, después del virus sincitial respiratorio. Por lo general, afecta a niños menores de cinco años y produce manifestaciones variables en las vías respiratorias superiores e inferiores. Asimismo, se ha asociado con el desarrollo de complicaciones neurológicas, lo que incrementa la morbilidad y mortalidad. Presentamos el caso de dos pacientes con sintomatología respiratoria asociada a alteraciones del sistema nervioso central dados por hiperreflexia, irritabilidad y convulsiones, con aislamiento de metapneumovirus humano por FilmArray™.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Panda S, Mohakud NK, Pena L, Kumar S. Human metapneumovirus: review of an important respiratory pathogen. Int J Infect Dis. 2014; 25: 45-52. doi: 10.1016/j.ijid.2014.03.1394.

  2. Céspedes PF, Palavecino CE, Kalergis AM, Bueno SM. Modulation of host immunity by the human metapneumovirus. Clin Microbiol Rev. 2016; 29(4): 795-818. doi: 10.1128/CMR.00081-15.

  3. Freymuth F, Vabret A, Legrand L, Dina J, Gouarin S, Cuvillon-Nimal D et al. Métapneumovirus humain. Pathol Biol. 2009; 57(2): 133-141. doi: 10.1016/j.patbio.2008.04.005.

  4. Arnold JC, Singh KK, Milder E, Spector SA, Sawyer MH, Gavali S et al. Human metapneumovirus associated with central nervous system infection in children. Pediatr Infect Dis J. 2009; 28(12): 1057-1060. doi: 10.1097/INF.0b013e3181acd221.

  5. Fernández IS, Polo MR, Muñoz-Almagro C, Carretero LM, Ureña SF, Muñoz AR et al. Human metapneumovirus in the cerebrospinal fluid of a patient with acute encephalitis. Arch Neurol. 2012; 69(5): 649-552. doi: 10.1001/archneurol.2011.1094.

  6. Ministerio de Salud y Protección Social Colombia. Boletín epidemiológico semanal. Sistema de Vigilancia en Salud Pública. 2018. pp. 1-31.

  7. Darniot M, Pitoiset C, Millière L, Aho-Glélé LS, Florentin E, Bour JB et al. Different meteorological parameters influence metapneumovirus and respiratory syncytial virus activity. J Clin Virol. 2018; 104: 77-82. doi: 10.1016/j.jcv.2018.05.002.

  8. Mizuta K, Abiko C, Aoki Y, Ikeda T, Matsuzaki Y, Itagaki T et al. Seasonal patterns of respiratory syncytial virus, influenza A virus, human metapneumovirus, and parainfluenza virus type 3 infections on the basis of virus isolation data between 2004 and 2011 in Yamagata, Japan. Jpn J Infect Dis. 2013; 66(2): 140-145.

  9. Montejano L, Noyola D. Infecciones por metapneumovirus humano en pacientes pediátricos. Rev enfermedades. Infecc en Pediatr. 2007; 20(79): 74-79.

  10. Edwards K, Zhu Y, Griffin M, Weinberg G, Hall C, Szilagyi P et al. Burden of human metapneumovirus infection in young children. N Engl J Med. 2013; 368(7): 633-643. doi: 10.1056/NEJMoa1204630.

  11. Principi N, Esposito S. Paediatric human metapneumovirus infection: Epidemiology, prevention and therapy. J Clin Virol. 2014; 59(3): 141-147. doi: 10.1016/j.jcv.2014.01.003.

  12. Schildgen V, van den Hoogen B, Fouchier R, Tripp RA, Alvarez R, Manoha C et al. Human metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev. 2011; 24(4): 734-754. doi: 10.1128/CMR.00015-11.

  13. Pancham K, Sami I, Perez GF, Huseni S, Kurdi B, Rose MC et al. Human metapneumovirus infection is associated with severe respiratory disease in preschool children with history of prematurity. Pediatr Neonatol. 2016; 57(1): 27-34. doi: 10.1016/j.pedneo.2015.03.008.

  14. Davis CR, Stockmann C, Pavia AT, Byington CL, Blaschke AJ, Hersh AL et al. Incidence, morbidity, and costs of human metapneumovirus infection in hospitalized children. J Pediatric Infect Dis Soc. 2016; 5(3): 303-311. doi: 10.1093/jpids/piv027.

  15. Lin P, Lin T, Huang YY, Tsao K, Huang YY. Human metapneumovirus and community-acquired pneumonia in children. Chang Gung Med J. 2005; 28(10): 683-638.

  16. Greensill J, McNamara PS, Dove W, Flanagan B, Smyth RL, Hart CA. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis. 2003; 9(3): 372-375.

  17. Semple MG, Cowell A, Dove W, Greensill J, McNamara PS, Halfhide C et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis [Internet]. 2005; 191(3): 382-386. doi: 10.1086/426457.

  18. Peiris JSM, Tang WH, Chan KH, Khong PL, Guan Y, Lau YL et al. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis. 2003; 9(6): 628-633. doi: 10.3201/eid0906.030009.

  19. Williams J, Harris P, Toilefson S, Halburnt-Rush L, Pingsterhaus J, Edwards K et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004; 350(5): 443-450. doi: 10.1056/NEJMoa025472.

  20. Williams J, Toilefson S, Nair S, Chonmaitree T. Association of human metapneumovirus with acute otitis media. Int J Pediatr Otorhinolaryngol. 2006; 70(7): 1189-1193. doi: 10.1016/j.ijporl.2005.12.007.

  21. Williams J, Crowe J, Enriquez R, Minton P, Stokes R, Hamilton R, et al. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis. 2005; 192(7): 1149-1153. doi: 10.1086/444392.

  22. Van den Hoogen BG, van Doornum GJJ, Fockens JC, Cornelissen JJ, Beyer WEP, de Groot R et al. Prevalence and clinical symptoms of human metapneumovirus infection. J Infect Dis. 2003; 188(10): 1571-1577. doi: 10.1086/379200.

  23. Niizuma T, Okumura A, Kinoshita K, Shimizu T. Acute encephalopathy associated with human metapneumovirus infection. Jpn J Infect Dis. 2014; 67: 213-215. doi: 10.7883/yoken.67.213.

  24. Schildgen O, Glatzel T, Geikowski T, Scheibner B, Matz B, Bindl L et al. Human metapneumovirus RNA in encephalitis patient. Emerg Infect Dis. 2005; 11(3): 467-470. doi: 10.3201/eid1103.040676.

  25. Wyde PR, Chetty SN, Jewell AM, Boivin G, Piedra PA. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res. 2003; 60(1): 51-59. doi: 10.1007/s00247-017-3943-5.

  26. Moe N, Krokstad S, Stenseng IH, Christensen A, Skanke LH, Risnes KR et al. Comparing human metapneumovirus and respiratory syncytial virus: Viral codetections, genotypes and risk factors for severe disease. PLoS One. 2017; 12(1): 1-19. doi: 10.1371/journal.pone.0170200.

  27. Ulbrandt ND, Ji H, Patel NK, Riggs JM, Brewah YA, Ready S et al. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo. J Virol. 2006;80(16): 7799-7806. doi: 10.1128/JVI.00318-06.

  28. Wen SC, Williams JV. New approaches for immunization and therapy against Human metapneumovirus. Clin Vaccine Immunol. 2015; 22(8): 858-866. doi: 10.1128/CVI.00230-15.

  29. Schuster JE, Cox RG, Hastings AK, Boyd KL, Wadia J, Chen Z et al. A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus. J Infect Dis. 2015; 211(2): 216-225. doi: 10.1093/infdis/jiu307.




2020     |     www.medigraphic.com